Affiliation:
1. Ist Orthopaedic Department, IRCCS—Istituto Ortopedico Rizzoli, via Giulio Cesare Pupilli 1, 40136 Bologna, Italy
2. Department of Biomedical and Neuromotor Science-DIBINEM, University of Bologna, 40123 Bologna, Italy
3. Infectious Diseases Unit, IRCCS Azienda Ospedaliero Universitaria di Bologna—Policlinico di Sant’Orsola, 40138 Bologna, Italy
Abstract
Background: Two-stage exchange (TSE) arthroplasty is currently considered the gold standard for chronic periprosthetic joint infections (PJIs), despite a failure rate reported in up to 10% of patients. Little is known about the risk factors that may compromise successful TSE arthroplasty management in such patients. The main purpose of the current study was to highlight the potential risk factors of patients with chronic PJIs after THA managed by implant removal, outlining the differences between reimplanted patients and those that were never reimplanted because of a non-eradicated infection. Methods: We conducted a retrospective observational study of patient candidates for TSE arthroplasty surgery, managed at the authors’ institution, over a four-year timeframe. The data were retrieved from the hospital’s information database. The enrolled population was divided into two Groups: A, reimplanted; B, non-reimplanted because of a non-eradicated infection within one year. For each Group, demographic information, PJI-related risk factors, type of pathogen and presence of single or polymicrobial infection, were collected and analyzed. Results: In total, 21 patients were included in the study, 14 patients in Group A and 7 in Group B. Major Depression (p = 0.049) and polymicrobial infection (p = 0.04) were more commonly observed in patients that were not reimplanted in the study period. No differences between the two groups were observed when other characteristics were compared. Conclusions: Patients with major depression, or those hosting polymicrobial periprosthetic hip infections, are more susceptible to failure of TSE arthroplasty procedures for chronic PJIs, hampering THA reimplantation. Current findings may drive further research and contribute to the understanding of the role of these risk factors in chronic PJI patients.
Reference42 articles.
1. Di Martino, A., Brunello, M., Bordini, B., Rossomando, V., Tassinari, L., D’Agostino, C., Ruta, F., and Faldini, C. (2023). Unstable Total Hip Arthroplasty: Should It Be Revised Using Dual Mobility Implants? A Retrospective Analysis from the R.I.P.O. Registry. J. Clin. Med., 12.
2. Debridement, Antibiotic Pearls, and Retention of the Implant in the Treatment of Infected Total Hip Arthroplasty;Ghirardelli;HIP Int.,2020
3. Risk Factors, Diagnosis and Management of Prosthetic Joint Infection after Total Hip Arthroplasty;Ahmed;Expert Rev. Med. Devices,2019
4. Following Total Hip Arthroplasty in Medicare Patients;Bozic;J. Bone Joint Surg. Am.,2012
5. Specificities of Total Hip and Knee Arthroplasty Revision for Infection;Jenny;Orthop. Traumatol. Surg. Res.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献